Approach to analyzing nucleic acid pharmaceuticals
In recent years, next generation pharmaceuticals have become more actively developed all over the world. Among them, nucleic acid pharmaceuticals have been on the market every year since 2016 and are typical novel modalities which are expected to be further development in the future. In drug development, evaluation of ‘drug metabolism and disposition’ is important, and quantitative analysis of drugs in biological samples is essential.